Archive entry.
The result showed that the Astartes's physiological responses were completely normal. All bodily functions remained at their pre-injection levels, and he had also gained the ability of "bulletproof skin."
After the Astartes volunteered for the experiment, it was learned that his skin was completely immune to close-range attacks from Small caliber Spike Rounds. Its limit was an attack from the Spike Rounds of a standard Gauss Rifle.
The Astartes had suffered a penetrating wound to the abdomen from an armor-piercing Spike Round. After treatment by The Hive's medical team, he had fully recovered and returned to his original unit.
This experiment confirmed that the improved Compound V could grant the Super Soldiers under Umbrella the ability of "bulletproof skin."
On January 1, 2047, the company began sequentially injecting the improved Compound V serum into its Spartan Primarch, Spartan I Warriors, Spartan-II, and Entire Astartes.
The injection program for all Super Soldiers was expected to be completed before the middle of 2047.
Furthermore, once a candidate completed the Astartes modification surgery and passed the recovery period, he would be directly injected with the improved Compound V serum.
The company now possessed tens of thousands of "invulnerable" Super Soldiers, further enhancing their combat survivability.
Note: The Super Soldiers' special skin had also caused the company some trouble. For example, after a soldier suffered severe injuries, ordinary medical needles could not be used to administer injections.
Therefore, the company needed to use Chromium-Titanium Alloy needles, together with mechanical arms, to administer medical injections to the Super Soldiers.
Project Name: Mark II Mjolnir Armor.
Access Level: A-rank and above.
Description:
The Mark II Mjolnir Armor was an improved version of the Mark I, developed by Dr. Catherine Russell.
The Mark I had a history of forty years. Whenever the company's